Loading clinical trials...
Loading clinical trials...
The objective of this study is to demonstrate the safety and performance of the M•care™ System for use in antenatal monitoring of pregnant women ≥ 32 weeks' gestation.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Marani Health
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
NCT06397794 · Lyme Disease, Post Treatment Lyme Disease, and more
NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more
NCT07233278 · Recurrent Pregnancy Loss(RPL), Anxiety
NCT05444283 · Recurrent Pregnancy Loss
NorthShore University Health System
Evanston, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions